Unknown

Dataset Information

The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events.


ABSTRACT:

Background

South Africa has among the highest incidence of multidrug-resistant tuberculosis (MDR-TB) and more than 70% of patients are HIV co-infected. MDR-TB treatment is associated with frequent adverse events (AEs). Although guidelines recommend concurrent treatment of MDR-TB and HIV, safety data on concurrent therapy are limited.

Methods

We conducted a prospective observational study of MDR-TB patients with and without HIV-coinfection in South Africa between 2011 and 2015. Participants received standardized MDR-TB and HIV regimens. Participants were followed monthly for the duration of MDR-TB therapy and screened for clinical and laboratory AEs. Audiometry was performed monthly during the intensive phase; color discrimination testing was performed every 2 months.

Resu

SUBMITTER: Smith JP 

PROVIDER: S-EPMC6903405 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature